Table 2 Inclusion and exclusion criteria for determining eligible studies
Inclusion criteria | Exclusion criteria | |
|---|---|---|
Language | English | None English language studies |
Population | People living with HIV (PLWH) | Studies which do not focus on PLWH or do not include PLWH |
Period | Studies published from 1 January 1996 to 30 June 2019 | Studies published before January 1996 |
Type of studies | Primary and secondary studies | Review articles (including systematic review and meta-analysis) However, reference list from review articles will be searched for further eligible studies |
Studies designs | Quantitative Qualitative Mixed methods Randomized controlled trial Cohort study (prospective observational study) Case-control study Cross-sectional study Case reports and series Ideas, editorials, opinions Crossover design | Animal research studies Test-tube lab research |
Study focus | Studies that report on either of the following: • Prescription drug diversion • Prescription drug misuse • Prescription drug abuse • Recreational/non-medical use/misuse/abuse/illicit/selling/trading/sharing/giving away/stealing/losing, and doctor shopping of prescribed drugs • Prevalence of prescription drug diversion, misuse or abuse • Practices of prescription drug diversion, misuse or abuse • Motives (other terms such as reasons, cause, purpose, intention, motivation, drive, and aim maybe used) of prescription drug diversion, misuse, or abuse • Risk factors of prescription drug diversion, misuse, or abuse • ART adherence | Studies that do not focus or report on the following: • Prescription drug diversion, misuse or abuse • Prevalence, practices, motives, risk factors and ART adherence associated with prescription drug diversion, misuse or abuse |
Drug classes | Studies that report on diversion, misuse, and abuse of the below drug classes: • Sedatives—including barbiturates, benzodiazepines, and sleep medications • Analgesics—including opioids heroin, morphine, hydromorphone, meperidine, oxycodone, hydrocodone, oxycodone, buprenorphine, methadone, fentanyl, and codeine • Stimulants—including cocaine, methamphetamine, amphetamine, and methylphenidate • Z-drugs (nonbenzodiazepines)—including imdazopyridines, cycloprrolones, pyrazolopyridines, and sleep medication • Anesthetic drugs • Antiretroviral drugs • Attention deficit hyperactivity disorder (ADHD) medication • Cannabinoids | Studies that report on diversion, misuse, and abuse of the below drug classes will be excluded: • Ecstasy drug—since it has no accepted medical indication |